Author

Zoe Fleischmann

Observed name: Z. Fleischmann

Institution: Foundation Medicine (United States)

Observed institution: Foundation Medicine (United States)

ORCID: 0000-0003-1616-802X

Observed ORCID: 0000-0003-1616-802X

OpenAlex ID: A5039601551

Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer

2023 · Jacob J. Orme, Fadi Taza, et al. · European Urology Oncology · 22

1182O Temozolomide treatment induces an MMR-dependent hypermutator phenotype in well differentiated pancreatic neuroendocrine tumors

2023 · L. de Mestier du Bourg, D. Cohen, et al. · Annals of Oncology · 8

Abstract 1249: Development of a pan-cancer algorithm to predict homologous recombination deficiency and sensitivity to PARPi therapy

2022 · Emmanuel Antonarakis, Jay Moore, et al. · Cancer Research · 8

Altered MDC1 Interactions and Dysfunctional DNA Repair in Lobular Breast Cancer Confers Sensitivity to PARP Inhibition

2026 · Joseph L. Sottnik, Madeleine T. Shackleford, et al. · Cancer Research · 5

Abstract 966: Exploration of a novel HRD signature (HRDsig) as a biomarker for rucaparib benefit in ARIEL2

2023 · Ethan S. Sokol, Russell W. Madison, et al. · Cancer Research · 3

Phenotypic POLE Variant Classification Identifies Patients Who May Have Favorable Prognosis and Benefit from Immunotherapy

2026 · Rachel B. Keller-Evans, Zoe Fleischmann, et al. · Journal of Molecular Diagnostics · 1

Abstract 305: POLE-specific variant classification strategy is critical for identifying patients who may benefit from immunotherapy

2023 · Rachel B. Keller, James Haberberger, et al. · Cancer Research · 1

1300P Exploration of a novel HRD signature (HRDsig) as a biomarker of first line FOLFIRINOX benefit in metastatic pancreatic cancer

2022 · A. Singhi, T. Chen, et al. · Annals of Oncology · 1

1734P Genomic landscape of pleural and peritoneal mesothelioma tumors

2021 · S. Hiltbrunner, Z. Fleischmann, et al. · Annals of Oncology · 1

Landscape of reversion alterations in homologous recombination genes reveals evolutionary constraints

2026 · Brennan Decker, Saumya D Sisoudiya, et al. · bioRxiv (Cold Spring Harbor Laboratory)

Abstract 101: Fragmentomics-based cancer type and subtype classification in 60,000 cell-free DNA samples.

2026 · Zhenjia Wang, Kevin Cabrera, et al. · Cancer Research

POLE variant phenotypic classification to enable identification of patients with colorectal cancer (CRC) who may benefit from immune checkpoint inhibition (ICI).

2024 · Rachel Beth Keller, Zoe Fleischmann, et al. · Journal of Clinical Oncology

Abstract 228: Recurrent mitochondrial mutations in thyroid cancer

2023 · Julia F. Hopkins, Zoe Fleischmann, et al. · Cancer Research

Abstract 931: Comprehensive analysis of 3,600 small cell lung cancer cases reveals rare genetic subtypes and multiple mechanisms of histological transformation

2023 · Smruthy Sivakumar, Jay A. Moore, et al. · Cancer Research

Works count: 14

Citation count: 49

H-index: 4

I10-index: 1